Welcome to LookChem.com Sign In|Join Free
  • or
2-chloro-5,6,8-trimethoxyquinoline is a quinoline derivative chemical compound characterized by the molecular formula C12H11ClN2O3. It features a quinoline ring with three methoxy groups and a chlorine atom attached, contributing to its unique chemical properties and potential applications in various fields.

42065-10-1

Post Buying Request

42065-10-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

42065-10-1 Usage

Uses

Used in Organic Synthesis:
2-chloro-5,6,8-trimethoxyquinoline serves as a building block in organic synthesis, providing a foundation for the creation of a wide range of chemical compounds. Its versatile structure allows for further functionalization and modification, making it a valuable component in the synthesis of complex organic molecules.
Used in Pharmaceutical Industry:
In the pharmaceutical industry, 2-chloro-5,6,8-trimethoxyquinoline is utilized as a key intermediate in the preparation of various pharmaceuticals. Its unique structure and potential biological activities make it a promising candidate for the development of new drugs with diverse therapeutic applications.
Used in Agrochemical Industry:
2-chloro-5,6,8-trimethoxyquinoline also finds application in the agrochemical industry, where it is employed in the synthesis of agrochemicals such as pesticides and herbicides. Its ability to be modified and functionalized allows for the development of novel compounds with improved efficacy and selectivity in agricultural settings.
Used in Antimalarial Research:
2-chloro-5,6,8-trimethoxyquinoline has been studied for its antimalarial properties, with potential to contribute to the development of new treatments for malaria. Its unique chemical structure and biological activities make it a valuable compound for research in this area.
Used in Anticancer Research:
2-chloro-5,6,8-trimethoxyquinoline has also demonstrated potential anticancer properties, making it a subject of interest in cancer research. Its ability to target and affect specific biological pathways involved in cancer progression positions 2-chloro-5,6,8-trimethoxyquinoline as a promising candidate for the development of novel anticancer drugs.

Check Digit Verification of cas no

The CAS Registry Mumber 42065-10-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 4,2,0,6 and 5 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 42065-10:
(7*4)+(6*2)+(5*0)+(4*6)+(3*5)+(2*1)+(1*0)=81
81 % 10 = 1
So 42065-10-1 is a valid CAS Registry Number.

42065-10-1Relevant academic research and scientific papers

Method of preparing Quinoline-5,8-dione derivatives for TGase 2 inhibitor

-

, (2020/04/28)

I Is -5,8- of the quinoline, dione derivative compound. of Formula I, or a stereoisomer or a pharmaceutically acceptable salt thereof, wherein the compound of Formula, TGase 2 has, inhibitory effects TGase 2, and thus the pharmaceutical composition may be useful for preventing or treating disorders or diseases mediated by TGase 2 or inhibiting. (by machine translation)

Quinoline-5,8-dione derivatives for TGase 2 inhibitor, and the pharmaceutical composition comprising the same

-

, (2019/10/29)

The present invention relates to a quinolin-5,8-dione derivative compound represented by chemical formula I, an optical isomer thereof or a pharmaceutically acceptable salt thereof. The compound represented by chemical formula I of the present invention has a TGase 2 inhibitory effect, and the pharmaceutical composition comprising the same can be usefully used for preventing or treating disorders or diseases mediated by TGase 2 or response to TGase 2 inhibition.COPYRIGHT KIPO 2020

Total synthesis of the antitumor antibiotic (±)-streptonigrin: First- and second-generation routes for de novo pyridine formation using ring-closing metathesis

Donohoe, Timothy J.,Jones, Christopher R.,Kornahrens, Anne F.,Barbosa, Luiz C. A.,Walport, Louise J.,Tatton, Matthew R.,O'Hagan, Michael,Rathi, Akshat H.,Baker, David B.

, p. 12338 - 12350 (2014/01/17)

The total synthesis of (±)-streptonigrin, a potent tetracyclic aminoquinoline-5,8-dione antitumor antibiotic that reached phase II clinical trials in the 1970s, is described. Two routes to construct a key pentasubstituted pyridine fragment are depicted, both relying on ring-closing metathesis but differing in the substitution and complexity of the precursor to cyclization. Both routes are short and high yielding, with the second-generation approach ultimately furnishing (±)-streptonigrin in 14 linear steps and 11% overall yield from inexpensive ethyl glyoxalate. This synthesis will allow for the design and creation of druglike late-stage natural product analogues to address pharmacological limitations. Furthermore, assessment of a number of chiral ligands in a challenging asymmetric Suzuki-Miyaura cross-coupling reaction has enabled enantioenriched (up to 42% ee) synthetic streptonigrin intermediates to be prepared for the first time.

Total synthesis of (±)-streptonigrin: De novo construction of a pentasubstituted pyridine using ring-closing metathesis

Donohoe, Timothy J.,Jones, Christopher R.,Barbosa, Luiz C. A.

supporting information; experimental part, p. 16418 - 16421 (2011/11/29)

The synthesis of the potent antitumor agent (±)-streptonigrin has been achieved in 14 linear steps and 11% overall yield from ethyl glyoxalate. The synthesis features a challenging ring-closing metathesis reaction, followed by elimination and aromatization, to furnish a key pentasubstituted pyridine fragment.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 42065-10-1